JP Morgan Initiates Metabolix at Neutral, $5 PT

December 12, 2011 5:59 AM | 6 seconds read | Make a Comment

JP Morgan has initiated coverage on Metabolix

MBLX

with a Neutral rating and $5 price target.

Posted In: Price Target Initiation Pre-Market Outlook Analyst Ratings Biotechnology Health Care JP Morgan

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.